medicina60巻6号

2023年05月発行

特集 Common diseaseの処方箋ファイル—臨床経過から学ぶ20症例

CASE 7 尿路感染症—受診当日からの排尿時痛で外来を受診した25歳女性

著者： 長野広之¹²

所属機関： ¹京都大学大学院医学研究科医療経済学分野博士課程 ²よしき往診クリニック

ページ範囲：P.842 - P.847

25歳女性
現病歴　受診当日からの排尿時痛で外来を受診した．排尿時痛以外にも残尿感や頻尿を認めている．以前も同様のエピソードが一度あるが，その際は自然に改善した．体熱感や悪寒戦慄，帯下の変化は認めていない．

参考文献

1）Hoffmann TC, et al：Uncomplicated urinary tract infection in women. BMJ 372：n725, 2021

2）Bent S, et al：Does this woman have an acute uncomplicated urinary tract infection? JAMA 287：2701-2710, 2002

3）Warren JW, et al：Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America（IDSA）. Clin Infect Dis 29：745-758, 1999

4）Matsumoto T, et al：Nationwide survey of antibacterial activity against clinical isolates from urinary tract infections in Japan（2008）. Int J Antimicrob Agents 37：210-218, 2011

5）Wilson ML, Gaido L：Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 3：1150-1158, 2004

6）Simerville JA, et al：Urinalysis；A comprehensive review. Am Fam Physician 71：1153-1162, 2005

7）Stamm WE, et al：Diagnosis of coliform infection in acutely dysuric women. N Engl J Med 307：463-468, 1982

8）Gupta K, et al：International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women；A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 52：e103-120, 2011

9）Hooton TM：Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 366：1028-1037, 2012

10）Ho JM, Juurlink DN：Considerations when prescribing trimethoprim-sulfamethoxazole. CMAJ 183：1851-1858, 2011

11）Matsumoto T, et al：Clinical effects of 2 days of treatment by fosfomycin calcium for acute uncomplicated cystitis in women. J Infect Chemother 17：80-86, 2011

12）AMR Clinical Reference Center：Surveillance of injectable antibiotic use by patient type（inpatient or outpatient）and age category, based on data from the NDB.　https://amrcrc.ncgm.go.jp/surveillance/010/Eng/EnInjection.pdf（2023年2月閲覧）

13）PDR： FDA Drug Safety Communication.　https://www.pdr.net/fda-drug-safety-communication/ceftriaxone?druglabelid=1723（2023年2月閲覧）

14）Hagiya H, et al：Ceftriaxone-induced neurotoxicity in a patient after pancreas-kidney transplantation. Intern Med 56：3103-3107, 2017

15）Patel IH, et al：Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment. Antimicrob Agents Chemother 25：438-442, 1984

16）Cohen D, et al：Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis. Antimicrob Agents Chemother 24：529-532, 1983

17）Park HZ, et al：Ceftriaxone-associated gallbladder sludge. Identification of calcium-ceftriaxone salt as a major component of gallbladder precipitate. Gastroenterology 100：1665-1670, 1991

18）Gupta K, Trautner BW：Diagnosis and management of recurrent urinary tract infections in non-pregnant women. BMJ 346：f3140, 2013

19）Scholes D, et al：Risk factors for recurrent urinary tract infection in young women. J Infect Dis 182：1177-1182, 2000

20）Dason S, et al：Guidelines for the diagnosis and management of recurrent urinary tract infection in women. Can Urol Assoc J 5：316-322, 2011

21）Hooton TM, et al：Effect of increased daily water intake in premenopausal women with recurrent urinary tract infections；A randomized clinical trial. JAMA Intern Med 178：1509-1515, 2018

22）Albert X, et al：Antibiotics for preventing recurrent urinary tract infection in non-pregnant women. Cochrane Database Syst Rev 2004：CD001209, 2004